Compass led a consortium of investors in acquiring 100% of Rameda in January 2011. The company manufactured human and veterinary pharmaceuticals in Egypt.
The consortium identified a business with established manufacturing infrastructure and room for improvement. The investment strategy focused on strengthening leadership, expanding the product portfolio, and improving production capabilities.
Historical update · 19 January 2011
Original announcement